1-[(2R)-2-aminobutanoyl]-N-(4-carbamimidoylbenzyl)-L-prolinamide

This compound is a synthetic small molecule dipeptide, formally named 1-[(2R)]-2‑aminobutanoyl]-N‑(4‑carbamimidoylbenzyl)‑L‑prolinamide. It has a molecular formula of C17H25N5O2 and a molecular weight of approximately 331.41 g/mol[6][8]. The structure features an aminobutyryl group linked to a prolinamide core, with a benzyl group substituted with a carbamimidoyl (guanidino) moiety. It is classified as an experimental drug and does not have any approved indications or known clinical trial activity beyond preclinical or early-stage research[8]. Its mechanism of action, pharmacological target(s), and therapeutic intent are not described in the available literature.

Other names

(2S)-1-[(2R)-2-aminobutanoyl]-N-[(4-carbamimidoylphenyl)methyl]pyrrolidine-2-carboxamide1-((2R)-2-aminobutanoyl)-N-(4-carbamimidoylbenzyl)-L-prolinamide(2S)-1-((2R)-2-aminobutanoyl)-N-((4-carbamimidoylphenyl)methyl)pyrrolidine-2-carboxamide